InSphero

📍 Schlieren, Switzerland🗓 Founded 2009👥 69 employees💰 Last funded 2015
Biotechnology Research🌐 insphero.com
Website LinkedIn
InSphero provides superior biological relevance to in vitro testing with easy-to-use solutions for production, culture and assessment of more organotypic 3D cell culture models. Our patented 3D cell culture platforms and methods enable large-scale, reproducible production of a broad range of assay-ready 3D InSight™ Microtissues derived from liver, pancreas, and tumor tissues. These models help to identify promising drugs and toxic liabilities with greater predictivity at early development stages, enabling better pre-clinical decision making, saving development cost, and shortening time to market. Microtissues are available directly or through a menu of 3D InSight™ Standard Services, supported by a comprehensive panel of 3D-optimized culture media, assay protocols, and imaging solutions. InSphero’s technologies drive significant findings in peer-reviewed journals, through collaborative projects such as EU Body on a Chip and HTS-DILI, and validation in the world’s largest government institutions and pharmaceutical, chemical and cosmetics companies. This 3D know-how is being applied in the diagnostics field to aid development of personalized chemotherapeutic strategies for the treatment of cancer. Founded in 2009 and privately held, InSphero is headquartered in Schlieren, Switzerland with subsidiaries in the United States (Brunswick, ME) and Waldshut, Germany. It has been recognized for its scientific and commercial achievements with a number of national and international awards.
3
Total investors
1
Early stage
1
Mid stage
1
Late stage
2009
Founded

Investors

3 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Switzerland
2
Investor activity2010–2015 · investors recorded per year
201012014120151
Recent (last 2y)Earlier
Frequently asked questions
Who invested in InSphero?
InSphero has 3 investors on record on gritt.io, including 1 early-stage backers, 1 mid-stage and 1 late-stage investors.
When did InSphero last raise funding?
The most recent investment in InSphero recorded on gritt.io was in 2015.
When was InSphero founded?
InSphero was founded in 2009.
What industry is InSphero in?
InSphero operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is InSphero based?
InSphero is headquartered in Schlieren, Switzerland.